Table 2 Baseline characteristics, details of early ECMO and outcomes
Case number | Case1 | Case2 | Case3 | Case4 | Case5 | Case6 |
|---|---|---|---|---|---|---|
Age (years) | 55 | 47 | 46 | 56 | 66 | 28 |
Sex | Male | Male | Male | Male | Male | Female |
Body surface area (m2) | 1.65 | 1.98 | 1.56 | 1.92 | 1.88 | 1.71 |
Causes of Airway obstruction | Airway compression by tumor + airway hemorrhage | Arterial bleeding compresses the airway | Airway compression by tumor + airway hemorrhage | Severe acute intractable asthma | Pulmonary hemorrhage due to aspergillus infection | The tracheal hemangioma was ruptured and bleeding |
ECMO mode | VV | VV | VV | VV | VV | VV |
Configuration | Fem-IJ | Fem-IJ | Fem-IJ | Fem-IJ | Fem-IJ | Fem-IJ |
Cannula size (French) (drainage/re-infusion) | 21/17 | 21/17 | 21/17 | 21/17 | 21/17 | 21/17 |
ECMO blood flow (l/min) | 3.5 | 3.6 | 3.4 | 3.5 | 3.1 | 3.6 |
Bolus UFH (U) | 0 | 0 | 0 | 0 | 100 | 0 |
Maintenance UFH (U/h) | 0 | 0 | 0 | 250 | 0 | 0 |
APTT during ECMO(lowest, highest)(s) | 46.2,49.5 | 33.3,38.5 | 29.2,30.7 | 55.6,66.8 | 24.8,34.5 | 29.2,33.3 |
Thrombotic events(Yes/No) | No | No | No | No | No | No |
ECMO duration (h) | 12 | 25 | 36 | 11 | 48 | 36 |
Intervention of airway obstruction after ECMO | tracheal stent + hemostasis | Surgery | tracheal stent + hemostasis | Glucocorticoids, β2 -agonists | pulmonary lobectomy | pulmonary lobectomy |
Weaning from ECMO(Yes/No) | Yes | Yes | Yes | Yes | Yes | Yes |
Length of hospitalization (days) | 34 | 18 | 7 | 11 | 13 | 55 |
Hospital survival(Yes/No) | Yes | Yes | Yes | Yes | No | Yes |